Howard Liang - Jun 18, 2021 Form 4 Insider Report for BeiGene, Ltd. (BGNE)

Role: CFO & Chief Strategy Officer
Signature: /s/ Qing Nian, as Attorney-in-Fact
Stock symbol: BGNE
Transactions as of: Jun 18, 2021
Transactions value $: -$158,383
Form type: 4
Date filed: 6/21/2021, 04:43 PM
Previous filing: Jun 9, 2021
Next filing: Jun 30, 2021

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BGNE	American Depositary Shares	Sale	-$158K	-486	-100%	$325.89	0	Jun 18, 2021	Direct	F1, F2
holding	BGNE	Ordinary Shares						1.56M	Jun 18, 2021	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each American Depositary Share represents 13 Ordinary Shares.
F2	The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/4th of the securities will vest on each anniversary of June 17, 2020, subject to continued service. Unvested securities are subject to accelerated vesting upon a sale event.

Content

Each American Depositary Share represents 13 Ordinary Shares.

The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/4th of the securities will vest on each anniversary of June 17, 2020, subject to continued service. Unvested securities are subject to accelerated vesting upon a sale event.